Celia Schiffer to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Celia Schiffer has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.010
-
Hensley ML, Peterson B, Silver RT, Larson RA, Schiffer CA, Szatrowski TP. Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013. J Clin Oncol. 2000 Mar; 18(6):1301-8.
Score: 0.010